Exosomes

Exosome therapy is at the forefront of regenerative medicine, utilising tiny extracellular vesicles called exosomes to boost cellular performance and support tissue regeneration. Administered intravenously (IV), this cuttingedgetreatment has shown promising results in clinical trials, demonstrating reduced inflammation and enhanced metabolic function.

We source our exosomes from human Umbilical Cord Mesenchymal Stem Cells (hUCMSC), selected after extensive research that demonstrated superior regenerative properties compared to other cell types. Key elements of our production process include:

• Serum-free media cultivation: This approach eliminates potential contaminants, ensuring consistent quality across batches for a purer, more effective product.
•  GMP-compliant materials and processes.
• Proprietary filtration technology Controlled environment
• Preservation techniques.

Product just available for clinics with prescribtion.